JUD care Obtains FDA Approval for Its Portable Ward sRoom
As a significant milestone and important recognition of the solution's reliability and effectiveness, FDA approval represents a major step forward in the global deployment of the sRoom.
- As a significant milestone and important recognition of the solution's reliability and effectiveness, FDA approval represents a major step forward in the global deployment of the sRoom.
- Currently, JUD care is in the process of obtaining relevant approval for the sRoom to enter the Brazilian and Russian markets.
- "As the world continues to battle the COVID-19 pandemic, JUD care firmly believes that our innovative patient isolation solution sRoom can serve as an effective tool in the fight," says He Wei, COO of JUD care.
- JUD care has already kicked off its International Partner Program to help bring the sRoom to organizations around the world.